-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OlVMzHml0xDiMBIOdY2Ld0azJEOFJ1ie3YJzNNST5dUkqS35xO9VPWKjd2Dneu8I BVbOZ2sMabUo0DF0GCoauQ== 0000902561-04-000342.txt : 20040810 0000902561-04-000342.hdr.sgml : 20040810 20040810152012 ACCESSION NUMBER: 0000902561-04-000342 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040810 GROUP MEMBERS: NONE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CARMIKE CINEMAS INC CENTRAL INDEX KEY: 0000799088 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MOTION PICTURE THEATERS [7830] IRS NUMBER: 581469127 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-37737 FILM NUMBER: 04964384 BUSINESS ADDRESS: STREET 1: 1301 FIRST AVE CITY: COLUMBUS STATE: GA ZIP: 31901 BUSINESS PHONE: 7065763400 MAIL ADDRESS: STREET 1: P O BOX 391 CITY: COLUMBUS STATE: GA ZIP: 31994 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: ZALAZNICK DAVID W CENTRAL INDEX KEY: 0001166818 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 767 FIFTH AVENUE 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10153 BUSINESS PHONE: 2125720800 MAIL ADDRESS: STREET 1: 767 FIFTH AVENUE 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10153 SC 13D/A 1 formsc13d-a_rw081004.txt DAVID W. ZALAZNICK DD AUGUST 3 2004 =============================================================================== SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13D (Rule 13d-101) Under the Securities Exchange Act of 1934 (Amendment No. 2) CARMIKE CINEMAS, INC. - ------------------------------------------------------------------------------- (Name of Issuer) COMMON STOCK, $0.03 PAR VALUE - ------------------------------------------------------------------------------- (Title of class of securities) 143436400 - ------------------------------------------------------------------------------- (CUSIP number) DAVID W. ZALAZNICK 767 FIFTH AVENUE, 48TH FLOOR NEW YORK, NEW YORK 10153 - ------------------------------------------------------------------------------- (Name, address and telephone number of person authorized to receive notices and communications) AUGUST 3, 2004 - ------------------------------------------------------------------------------- (Date of event which requires filing of this statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [_]. NOTE: Schedules filed in paper format shall include a signed original and five copies of the Schedule, including all exhibits. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act. (Continued on following pages) (Page 1 of 8 pages) =============================================================================== - -------------------- -------------------------- CUSIP No. 143436400 13D - -------------------- -------------------------- - ----------- ------------------------------------------------------------------- 1 NAME OF REPORTING PERSON: David W. Zalaznick S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: - ----------- -------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [_] (b) [x] - ----------- -------------------------------------------------------------------- 3 SEC USE ONLY - ----------- ------------------------------- ------------------------------------ 4 SOURCE OF FUNDS: N/A - ----------- -------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) OR 2(e): [_] - ----------- -------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION: United States - --------------------- ------- -------------------------------------------------- NUMBER OF 7 SOLE VOTING POWER: 87,908 (see Items 5 and 6) SHARES ------- -------------------------------------------------- BENEFICIALLY 8 SHARED VOTING POWER: -0- OWNED BY ------- -------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER: 87,908 (see Items 5 and 6) REPORTING ------- -------------------------------------------------- PERSON WITH 10 SHARED DISPOSITIVE POWER: -0- - ----------- -------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED 87,908* (see Items 5 and 6) BY REPORTING PERSON: - ----------- -------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES: [_] - ----------- -------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11): 0.72%** - ----------- -------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON: IN - ----------- -------------------------------------------------------------------- * If the underwriters party to the underwriting agreement, dated August 3, 2004 (the "August 2004 Underwriting Agreement"), entered into with Carmike Cinemas, Inc. (the "Company") and the selling stockholders party thereto, relating to the Company's public offering of shares of its Common Stock, exercise the over-allotment option granted pursuant to the August 2004 Underwriting Agreement (the "August 2004 Over-Allotment Option") in full then this amount will decrease to 25 shares. The August 2004 Over-Allotment Option is exercisable within 30 days after the date of the August 2004 Underwriting Agreement. ** If the underwriters party to the August 2004 Underwriting Agreement exercise the August 2004 Over-Allotment Option in full then this percentage will be less than 0.01%. Page 2 of 8 ITEM 1. SECURITY AND ISSUER. This Amendment No. 2 relates to the common stock, $0.03 par value per share, (the "Common Stock"), of Carmike Cinemas, Inc., a Delaware corporation (the "Company") and amends and supplements the Schedule 13D filed by the Beneficial Owners with the Securities and Exchange Commission (the "SEC") on February 11, 2002 (as amended by Amendment No. 1 filed on February 20, 2004, the "Schedule 13D"). The address of the principal executive office of the Company is 1301 First Avenue, Columbus, Georgia 31901. Capitalized terms used herein but not otherwised defined herein shall have the meanings ascribed to such terms in the Schedule 13D. ITEM 4. PURPOSE OF THE TRANSACTION. Item 4 is hereby amended by adding the following at the end thereof: On August 3, 2004, the Beneficial Owners entered into an Underwriting Agreement (the "August 2004 Underwriting Agreement") with the Company, the other selling stockholders listed in Schedule II to the Underwriting Agreement (together with the Beneficial Owners, the "August 2004 Selling Stockholders"), and Goldman Sachs, as representative of the several underwriters listed in Schedule I to the August 2004 Underwriting Agreement (collectively, the "August 2004 Underwriters"). The August 2004 Underwriting Agreement provides for purchases by the August 2004 Underwriters from the August 2004 Selling Stockholders of 4,332,415 shares of Common Stock (collectively, the "August 2004 Initial Sale"). Of the shares of Common Stock to be sold by the August 2004 Selling Stockholders in the August 2004 Initial Sale, The Beneficial Owners agreed to sell 586,057 shares. In addition, pursuant to the August 2004 Underwriting Agreement, the August 2004 Selling Stockholders granted the August 2004 Underwriters an option, exercisable within 30 days after the date of the August 2004 Underwriting Agreement, to purchase an additional 649,836 shares of Common Stock at the same purchase price per share for the purpose of covering over-allotments (the "August 2004 Over-Allotment Option"). Of the 649,836 shares of Common Stock to be sold by the August 2004 Selling Stockholders upon the exercise in full by the August 2004 Underwriters of the August 2004 Over-Allotment Option, the Beneficial Owners agreed to sell 87,883 shares. Pursuant to the final prospectus (the "August 2004 Offering Prospectus") filed by the Company on August 3, 2004 (the "August 2004 Offering Prospectus Date") pursuant to Rule 424 of the Securities Act, the public offering price in the public offering of Common Stock by the Company is $33.00 per share and the underwriting discount is $1.485 per share. Pursuant to the August 2004 Underwriting Agreement, the August 2004 Underwriters agreed to purchase shares of Common Stock in the August 2004 Initial Sale and upon exercise of the August 2004 Over-Allotment Option at a price per share of $31.515 (which is net of underwriting discounts and commissions). The August 2004 Underwriting Agreement contains standard terms and conditions for a public offering including customary representations and warranties and indemnity provisions. The foregoing description of the August 2004 Underwriting Agreement is not intended to be complete and is qualified in its entirety by the complete Page 3 of 8 text of the August 2004 Underwriting Agreement, a copy of which is filed as Exhibit 7 hereto. Pursuant to the August 2004 Underwriting Agreement, the Beneficial Owners agreed to sell 673,940 shares of Common Stock to the August 2004 Underwriters, consisting of (i) 586,057 shares of Common Stock sold upon consummation of the August 2004 Initial Sale and (ii) 87,883 shares of Common Stock sold upon exercise in full by the August 2004 Underwriters of the August 2004 Over-Allotment Option, in each case, at a price per share of $31.515 (which is net of underwriting discounts and commissions), for an aggregate amount of $21,239,219.10 (which consists of $18,469,586.36 received by the Beneficial Owners upon consummation of the August 2004 Initial Sale and $2,769,632.75 that would be received by the Beneficial Owners upon the August 2004 Underwriters' exercise of the August 2004 Over-Allotment Option in full). The consummation of the August 2004 Initial Sale occurred on August 9, 2004 (the "August 2004 Initial Sale Closing Date"). David W. Zalaznick has resigned from the Company's Board of Directors, effective as of the August 2004 Initial Sale Closing Date. Additional information is included in the response to Item 6 of this Amendment No. 2 and the Schedule 13D, which Item is incorporated herein by reference. Except as set forth above, the Beneficial Owners have no present plans or intentions which would result in or relate to any of the transactions described in subparagraphs (a) through (j) of Item 4 of the Schedule 13D. ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. Items 5(a)-(c) are hereby amended in their entirety as follows: (a) Based on information reported by the Company in the August 2004 Offering Prospectus, after the consummation of the August 2004 Initial Sale on August 9, 2004, there were 12,152,622 shares of Common Stock outstanding as of the close of business on August 9, 2004 (the "Outstanding Shares") and the Beneficial Owners beneficially own 87,908 shares of Common Stock representing approximately 0.72% of the Outstanding Shares. (b) Item 5(a) and Item 6 of this Amendment No. 2 and the Schedule 13D are incorporated herein by reference. (c) Except as set forth above, none of the Beneficial Owners, nor to the best of their knowledge, any of their executive officers or directors, has effected any transaction in any securities of the Company during the past 60 days. Page 4 of 8 ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. Item 6 is hereby amended by adding the following at the end thereof: The responses set forth in Item 4 of this Amendment No. 2 and the Schedule 13D are incorporated herein by reference in their entirety. Lock-Up Agreement. In connection with the August 2004 Initial Sale, the Company, its executive officers and directors and the August 2004 Selling Stockholders have agreed not to offer, sell, contract to sell, pledge, grant any option to purchase, make any short sale or otherwise dispose of any shares of Common Stock, or any options or warrants to purchase any shares of Common Stock, or any securities convertible into, exchangeable for or that represent the right to receive shares of Common Stock, whether owned at the time of such agreement or acquired thereafter, owned directly by such person (including holding as a custodian) or with respect to which such person has beneficial ownership within the rules and regulations of the SEC during the period beginning from the August 2004 Offering Prospectus Date and continuing to and including the date that is 90 days after the August 2004 Offering Prospectus Date, without the prior written consent of Goldman Sachs as representative of the August 2004 Underwriters (the "August 2004 Lock-Up Agreement"). The foregoing description of the August 2004 Lock-Up Agreement is not intended to be complete and is qualified in its entirety by the complete text of the August 2004 Lock-Up Agreement, the form of which is filed as Exhibit 8 hereto. Page 5 of 8 ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Item 7 is hereby amended to add the following to the end thereof: 7. Underwriting Agreement, dated August 3, 2004, by and among Carmike Cinemas, Inc., the Selling Stockholders listed in Schedule II thereto, and Goldman, Sachs & Co., as representative of the several underwriters listed in Schedule I thereto (filed as Exhibit 99.18 to Amendment No. 4 to the Schedule 13D of Goldman, Sachs & Co., et al, relating to the Company's Common Stock, filed on August 4, 2004 (the "Goldman, Sachs August 2004 Schedule 13D").* 8. Form of Lock-Up Agreement (filed as Exhibit 99.19 to the Goldman, Sachs August 2004 Schedule 13D).* _________ * Incorporated herein by reference. Page 6 of 8 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: August 10, 2002 DAVID ZALAZNICK AND BARBARA ZALAZNICK, JT TEN /S/ DAVID W. ZALAZNICK ----------------------------------- BY: DAVID W. ZALAZNICK Title: Joint Tenant /S/ BARBARA ZALAZNICK ----------------------------------- BY: BARBARA ZALAZNICK Title: Joint Tenant Page 7 of 8 EXHIBIT INDEX Exhibit No. Description Page No. - ----------- ----------- -------- 7 Underwriting Agreement, dated August 3, 2004, by and * among Carmike Cinemas, Inc., the Selling Stockholders listed in Schedule II thereto, and Goldman, Sachs & Co., as representative of the several underwriters listed in Schedule I thereto (filed as Exhibit 99.18 to Amendment No. 4 to the Schedule 13D of Goldman, Sachs & Co., et al, relating to the Company's Common Stock, filed on August 4, 2004 (the "Goldman, Sachs August 2004 Schedule 13D"). 8 Form of Lock-Up Agreement (filed as Exhibit 99.19 to * the Goldman, Sachs August 2004 Schedule 13D). - -------- * Incorporated herein by reference. Page 8 of 8 -----END PRIVACY-ENHANCED MESSAGE-----